DocCheck AG

XTRA:AJ91 Stock Report

Market Cap: €41.6m

DocCheck Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Frank Antwerpes

Chief executive officer

€244.7k

Total compensation

CEO salary percentage75.5%
CEO tenureno data
CEO ownership55.7%
Management average tenure5.3yrs
Board average tenure25.9yrs

Recent management updates

What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Dec 07
What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Recent updates

DocCheck's (ETR:AJ91) Returns On Capital Not Reflecting Well On The Business

Nov 19
DocCheck's (ETR:AJ91) Returns On Capital Not Reflecting Well On The Business

We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings

Apr 19
We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings

DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger

Aug 04
DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger

Estimating The Fair Value Of DocCheck AG (ETR:AJ91)

May 20
Estimating The Fair Value Of DocCheck AG (ETR:AJ91)

The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested

Nov 06
The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested

Returns On Capital Are A Standout For DocCheck (ETR:AJ91)

Mar 03
Returns On Capital Are A Standout For DocCheck (ETR:AJ91)

If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Jan 18
If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?

Aug 26
Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?

Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?

May 02
Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?

Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital

Apr 18
Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital

Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?

Mar 23
Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?

Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Mar 04
Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?

Feb 14
Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?

Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?

Jan 27
Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?

Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive

Jan 10
Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive

If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Dec 22
If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Dec 07
What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Nov 22
DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

CEO Compensation Analysis

How has Frank Antwerpes's remuneration changed compared to DocCheck's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

€2m

Mar 31 2024n/an/a

€2m

Dec 31 2023€245k€185k

€2m

Sep 30 2023n/an/a

€4m

Jun 30 2023n/an/a

€6m

Mar 31 2023n/an/a

€6m

Dec 31 2022€250k€190k

€6m

Sep 30 2022n/an/a

€7m

Jun 30 2022n/an/a

€7m

Mar 31 2022n/an/a

€9m

Dec 31 2021€250k€190k

€11m

Sep 30 2021n/an/a

€12m

Jun 30 2021n/an/a

€13m

Mar 31 2021n/an/a

€11m

Dec 31 2020€211k€151k

€9m

Sep 30 2020n/an/a

€7m

Jun 30 2020n/an/a

€4m

Mar 31 2020n/an/a

€4m

Dec 31 2019€245k€185k

€3m

Sep 30 2019n/an/a

€3m

Jun 30 2019n/an/a

€3m

Mar 31 2019n/an/a

€3m

Dec 31 2018€244k€184k

€2m

Sep 30 2018n/an/a

€2m

Jun 30 2018n/an/a

€2m

Mar 31 2018n/an/a

€2m

Dec 31 2017€237k€177k

€2m

Compensation vs Market: Frank's total compensation ($USD255.16K) is below average for companies of similar size in the German market ($USD468.18K).

Compensation vs Earnings: Frank's compensation has been consistent with company performance over the past year.

CEO

Frank Antwerpes

no data

Tenure

€244,721

Compensation

Dr. Frank Nicolas Antwerpes serves as the Chief Executive Officer at DocCheck Guano AG. He served as the Chief Executive Officer of DocCheck Medizinbedarf und Logistik GmbH. Dr. Antwerpes serves as Preside...

Leadership Team

NamePositionTenureCompensationOwnership
Frank Antwerpes
President of the Management Board & CEOno data€244.72k55.71%
€ 23.2m
Philip Stadtmann
CFO & Member of Management Board5.3yrs€232.41kno data
Thilo Kolzer
COO & Member of Management Board5.3yrs€234.81kno data
Jens Knoop
CTO & Member of Management Board5.3yrs€195.80kno data

5.3yrs

Average Tenure

Experienced Management: AJ91's management team is seasoned and experienced (5.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Joachim Pietzko
Chairman of the Supervisory Board25.9yrs€19.20kno data
Winfried Leimeister
Deputy Chairwoman of the Supervisory Board25.9yrs€9.60kno data
Karin Immenroth
Chief Data & Analytics Officer and Member of Supervisory Board2.6yrs€9.60kno data

25.9yrs

Average Tenure

Experienced Board: AJ91's board of directors are seasoned and experienced ( 25.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 08:44
End of Day Share Price 2024/12/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DocCheck AG is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution